Medicine
Pharmaceuticals
Product Number : 0085-4347-01
Antineoplastic Agent
Indication
Sylatron™ is an alpha interferon indicated for the adjuvant treatment of
melanoma with microscopic or gross nodal involvement within 84 days of
definitive surgical resection including complete lymphadenectomy.
Benefit
Sylatron (peginterferon alfa-2b) is made from human proteins that help the body fight viral infections
